|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/63 | (2006.01) |
| C12N 15/63 | (2013.01) | ||
| C12N 15/67 | (2006.01) | ||
| C12N 15/67 | (2013.01) | ||
| C12Q2531/125 | (2013.01) |
| (11) | Patento numeris | 3684934 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18778820.3 |
| Europos patento paraiškos padavimo data | 2018-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-07-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-06-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/074559 |
| Data | 2018-09-12 |
| (87) | Numeris | WO 2019/053039 |
| Data | 2019-03-21 |
| (30) | Numeris | Data | Šalis |
| 201715707074 | 2017-09-18 | US |
| (72) |
DAVIS, Brian, Michael , US
NELSON, John, Richard , US
GAO, Wei , US
|
| (73) |
Global Life Sciences Solutions Operations UK Ltd ,
19 Jessops Riverside
800 Brightside Lane, Sheffield, S9 2RX,
GB
|
| (54) | IN VIVO RNA OR PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATEMERIC DNA INCLUDING PHOSPHOROTHIOATED NUCLEOTIDES |
| IN VIVO RNA OR PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATEMERIC DNA INCLUDING PHOSPHOROTHIOATED NUCLEOTIDES |